Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock

<i>Background and Objectives</i>. Recent guidelines have downgraded the routine use of the intra-aortic balloon pump (IABP) in patients with cardiogenic shock (CS) due to ST-elevation myocardial infarction (STEMI). Despite this, its use in clinical practice remains high. The aim of this...

Full description

Bibliographic Details
Main Authors: Alberto Somaschini, Stefano Cornara, Sergio Leonardi, Andrea Demarchi, Alessandro Mandurino-Mirizzi, Federico Fortuni, Marco Ferlini, Gabriele Crimi, Rita Camporotondo, Massimiliano Gnecchi, Luigi Oltrona Visconti, Stefano De Servi, Gaetano Maria De Ferrari
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/10/1806
_version_ 1797572981935833088
author Alberto Somaschini
Stefano Cornara
Sergio Leonardi
Andrea Demarchi
Alessandro Mandurino-Mirizzi
Federico Fortuni
Marco Ferlini
Gabriele Crimi
Rita Camporotondo
Massimiliano Gnecchi
Luigi Oltrona Visconti
Stefano De Servi
Gaetano Maria De Ferrari
author_facet Alberto Somaschini
Stefano Cornara
Sergio Leonardi
Andrea Demarchi
Alessandro Mandurino-Mirizzi
Federico Fortuni
Marco Ferlini
Gabriele Crimi
Rita Camporotondo
Massimiliano Gnecchi
Luigi Oltrona Visconti
Stefano De Servi
Gaetano Maria De Ferrari
author_sort Alberto Somaschini
collection DOAJ
description <i>Background and Objectives</i>. Recent guidelines have downgraded the routine use of the intra-aortic balloon pump (IABP) in patients with cardiogenic shock (CS) due to ST-elevation myocardial infarction (STEMI). Despite this, its use in clinical practice remains high. The aim of this study was to evaluate the prognostic impact of the IABP in patients with STEMI complicated by CS undergoing primary PCI (pPCI), focusing on patients with anterior MI in whom a major benefit has been previously hypothesized. <i>Materials and Methods.</i> We enrolled 2958 consecutive patients undergoing pPCI for STEMI in our department from 2005 to 2018. Propensity score matching and mortality analysis were performed. <i>Results</i>. CS occurred in 246 patients (8.3%); among these patients, 145 (60%) had anterior AMI. In the propensity-matched analysis, the use of the IABP was associated with a lower 30-day mortality (39.3% vs. 60.9%, <i>p</i> = 0.032) in the subgroup of patients with anterior STEMI. Conversely, in the whole group of CS patients and in the subgroup of patients with non-anterior STEMI, IABP use did not have a significant impact on mortality. <i>Conclusions</i>. The use of the IABP in cases of STEMI complicated by CS was found to improve survival in patients with anterior infarction. Prospective studies are needed before abandoning or markedly limiting the use of the IABP in this clinical setting.
first_indexed 2024-03-10T21:04:28Z
format Article
id doaj.art-1fc12e2142314f60b0f0c214913171cd
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T21:04:28Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-1fc12e2142314f60b0f0c214913171cd2023-11-19T17:17:31ZengMDPI AGMedicina1010-660X1648-91442023-10-015910180610.3390/medicina59101806Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic ShockAlberto Somaschini0Stefano Cornara1Sergio Leonardi2Andrea Demarchi3Alessandro Mandurino-Mirizzi4Federico Fortuni5Marco Ferlini6Gabriele Crimi7Rita Camporotondo8Massimiliano Gnecchi9Luigi Oltrona Visconti10Stefano De Servi11Gaetano Maria De Ferrari12Cardiac Intensive Care Unit, Division of Cardiology, San Paolo Hospital, 17100 Savona, ItalyCardiac Intensive Care Unit, Division of Cardiology, San Paolo Hospital, 17100 Savona, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDivision of Cardiology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyInterventional Cardiology Unit, CardioThoraco Vascular Department (DICATOV), IRCCS Ospedale Policlinico San Martino, 16132 Genova, ItalyDivision of Cardiology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDivision of Cardiology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDepartment of Molecular Medicine, Unit of Cardiology, University of Pavia, 27100 Pavia, ItalyDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital, 10126 Turin, Italy<i>Background and Objectives</i>. Recent guidelines have downgraded the routine use of the intra-aortic balloon pump (IABP) in patients with cardiogenic shock (CS) due to ST-elevation myocardial infarction (STEMI). Despite this, its use in clinical practice remains high. The aim of this study was to evaluate the prognostic impact of the IABP in patients with STEMI complicated by CS undergoing primary PCI (pPCI), focusing on patients with anterior MI in whom a major benefit has been previously hypothesized. <i>Materials and Methods.</i> We enrolled 2958 consecutive patients undergoing pPCI for STEMI in our department from 2005 to 2018. Propensity score matching and mortality analysis were performed. <i>Results</i>. CS occurred in 246 patients (8.3%); among these patients, 145 (60%) had anterior AMI. In the propensity-matched analysis, the use of the IABP was associated with a lower 30-day mortality (39.3% vs. 60.9%, <i>p</i> = 0.032) in the subgroup of patients with anterior STEMI. Conversely, in the whole group of CS patients and in the subgroup of patients with non-anterior STEMI, IABP use did not have a significant impact on mortality. <i>Conclusions</i>. The use of the IABP in cases of STEMI complicated by CS was found to improve survival in patients with anterior infarction. Prospective studies are needed before abandoning or markedly limiting the use of the IABP in this clinical setting.https://www.mdpi.com/1648-9144/59/10/1806acute myocardial infarctioncardiogenic shockmechanical circulatory supportIABP
spellingShingle Alberto Somaschini
Stefano Cornara
Sergio Leonardi
Andrea Demarchi
Alessandro Mandurino-Mirizzi
Federico Fortuni
Marco Ferlini
Gabriele Crimi
Rita Camporotondo
Massimiliano Gnecchi
Luigi Oltrona Visconti
Stefano De Servi
Gaetano Maria De Ferrari
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
Medicina
acute myocardial infarction
cardiogenic shock
mechanical circulatory support
IABP
title Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
title_full Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
title_fullStr Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
title_full_unstemmed Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
title_short Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
title_sort beneficial effects of iabp in anterior myocardial infarction complicated by cardiogenic shock
topic acute myocardial infarction
cardiogenic shock
mechanical circulatory support
IABP
url https://www.mdpi.com/1648-9144/59/10/1806
work_keys_str_mv AT albertosomaschini beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT stefanocornara beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT sergioleonardi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT andreademarchi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT alessandromandurinomirizzi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT federicofortuni beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT marcoferlini beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT gabrielecrimi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT ritacamporotondo beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT massimilianognecchi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT luigioltronavisconti beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT stefanodeservi beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock
AT gaetanomariadeferrari beneficialeffectsofiabpinanteriormyocardialinfarctioncomplicatedbycardiogenicshock